Unknown

Dataset Information

Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.


ABSTRACT: The early detection of cognitive decline in Parkinson's disease is important for providing drug therapy and non-pharmacological management. The circulating microRNAs present in plasma are promising biomarkers of PD with dementia (PDD) due to their critical roles in synaptic plasticity and the regulation of neurodegeneration-associated proteins. In this study, we aimed to identify plasma microRNAs that may differentiate PD with or without cognitive impairment. Global microRNA expression was obtained from a discovery set of 123 participants who were divided into four groups, namely normal controls (HC), PD with no dementia (PDND), PD with mild cognitive impairment (PD-MCI), and PDD, using next-generation sequencing. The BOLD selector was used for microRNA candidate selection. Six miRNAs, nam

SUBMITTER: Hsu YF 

PROVIDER: S-EPMC10970771 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature